Parametrica Management LTD Bristol Myers Squibb CO Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $225,476 - $245,543	-3,642 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $216,116 - $243,067	3,642 New	3,642 $231,000
Q1 2018 Apr 24, 2018	SELL	$59.92 - $68.98 $205,645 - $236,739	-3,432 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$59.94 - $65.35 $205,714 - $224,281	3,432	3,432 $210,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.